“In-Silico Drug Design And Adme Studies Of Substituted 1, 3, 4-Oxadiazole Analogues As Potent Mycobacterial Dpre1 Enzyme Inhibitors” (2023) Journal of Pharmaceutical Negative Results, pp. 2793–2803. doi:10.47750/pnr.2023.14.S02.329.